Monday, October 26, 2026

9 New Automation Projects Focused on U.S. COVID-19 Recovery

ViaNews Editorial Team

October 19, 2020

Photo by Dmitriy Suponnikov on Unsplash

Technology has played a critical role in helping us adapt to the maelstrom of disruption caused by the coronavirus pandemic and the new realities of daily life.

Amongst all technological innovations, automation has proved to be a major optimization lever reshaping industries across the globe.

The trust of businesses in the power of automation is reflected in recent stepped-up efforts by the Advanced Robotics for Manufacturing Institute, a leading public-private partnership that catalyzes robotics and workforce solutions to strengthen the U.S. industrial base.

ARM, which is funded by the Department of Defense (DoD), has chosen nine technical projects to help the U.S. economy recover faster from the COVID-19 outbreak that forced almost all businesses to look at their strategies afresh.

Read more: What Are the Main Imperatives for Automation Success?

The identified areas of urgency include diagnostics, medical care and countermeasures, non-medical personal protective equipment, and other supplies, according to the Robot Report.

The selected projects are linked to the virus's containment and the capabilities of the U.S. and the DoD to prevent, prepare for, and respond to the current and future crises.

The Robot Report says ARM plans to award around $5 million in funding, for a total contributed investment of approximately $8 million across the projects briefly described below:

1- Autonomous Robotic Spraying and Disinfection in Warehouses and Shipyards 

In light of the need for more frequent and reliable disinfection to control the spread of the coronavirus in the facilities producing medical supplies and essential goods, this project will develop an autonomous warehouse disinfection system.

The system will minimize the human role in potentially harmful disinfecting procedures and reduce costs by automatically navigating, locating, and disinfecting heavily touched surfaces and potentially contaminated areas.

2- Automation of Characterization and Evaluation (ACE) in Personal Protective Equipment (PPE) Manufacturing   

As sample testing of PPE has become a priority in manufacturing plants and medical centers, this project is aimed at developing a robotic system to automate the quality assurance tests for PPE inspection.

It is expected to improve the performance, productivity, and efficiency of PPE manufacturing in the U.S.

3- Built-By-Bot: Customized Mask Assembly Using Robots  

Cloth masks have been playing a huge role in slowing the spread of COVID-19. However, the supply has not been able to fully meet the demand.

Building upon the outputs from other ARM projects, this initiative will automate the robotic production of cloth face masks. 

4- Mobile Autonomous Industrial Disinfector (MAID)   

Businesses and workspaces require frequent surface disinfection to operate safely, but the current method of manual cleaning is not ideal.

This project seeks to develop an autonomous mobile robot with a mounted collaborative multi-axis robotic arm capable of manipulating both a disinfection system and a sensor suite.

5- Rapid PPE Production Through Automation and Robotics (RAPPAR)   

Existing automated mask production in the U.S. is slated to improve with the implementation of this project, which will include robotic automatic visual inspection, picking-and-sorting, and end-of-line packing and palletizing. 

6- Autonomous Mobile Capability for Room Disinfecting Robots   

This project is aimed at adding mobile autonomous capabilities to the Decon–X (DX1) disinfection system to automate the consecutive treatment of multiple rooms and spaces within workplaces.

Read more: Automation, Customization Key to Survival of Independent Hotels: Climber CEO

7- Rapid Robotic Diagnostic Kit Discovery   

This project will develop a solution using advanced vision systems and flexible robots to accelerate COVID-19 Lateral Flow Assay (LFA) tests, which will dramatically help America’s efforts toward large-scale testing for current and future pandemics.

8- Swarm Robotics for Large Structure Manufacturing  

Amid the coronavirus pandemic, air-supported structures are ideal to be used as expeditionary hospitals, quarantine facilities, housing, and other disaster relief or military applications.  

Production of these structures can be expedited with the development of robotic technology. This project seeks to aid manufacturing personnel with moving and manipulating heavy, flexible materials.

9- Robotic Application of Anti-Microbial Copper Coatings  

The need for self-disinfecting surfaces has been highlighted by COVID-19. This project will develop a robotic anti-microbial copper application system to improve the manufacturability of these parts.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com